Scientists make use of tissue-like, bioengineered hydrogels to keep the patient’s tumor alive even after it has been removed from the body. This process helps to customize the treatment plan and significantly reduces drug testing and screening time for cancer patients.

A new heart disease calculator has been developed by experts which helps to accurately predict an individual's ten-year risk of cardiovascular diseases, like heart disease and stroke, particularly identifying high-risk patients that current prediction tools miss.

In a new study, scientists have discovered that chemotherapy-resistant ovarian cancer cells and tumors are rich in cholesterol. A new treatment approach with a nanoparticle has the capacity to starve cells of cholesterol, thus reducing ovarian tumor growth by more than 50 % in human cells and animal models.

Shimadzu’s new imscope QT imaging mass microscope is claimed to be the only instrument in the world that can obtain mass spectral data associated with morphological information.

Researchers have developed a new microscopy technology called decrowding expansion pathology (dexpath) which is capable of providing detailed images of brain cancer tissue. The potential technology can be used for gaining insights into brain cancer development as well as other aggressive neurological diseases.

Researchers have now revealed new compounds that are capable of offering the same benefits as exercise. This discovery could play a potential role in treating patients with muscle atrophy and other medical conditions.

Researchers at The University of Texas at Austin are making use of artificial intelligence and biosensors to develop drugs faster. They are currently utilizing AI and genetically modified bacteria to ferment the Alzheimer’s drug Galantamine.

The National Research Foundation has funded 36 million dollars to the National University of Singapore’s Mechanobiology Institute for developing biomedical innovations for infertility, muscle loss and cancer.

The BCL6 gene has been previously associated with immune system function. A new study has revealed that deleting the gene in utero or in adult mice resulted in 30 % loss in muscle mass.

Researchers led by Professor Gary Lewin at the Max Delbrück Center have identified a new ion channel, Elkin1, crucial for touch perception, complementing the previously known Piezo2 channel. This discovery, confirmed through experiments on mice and human sensory neurons, opens new avenues for understanding touch and potentially treating chronic pain.